TOPOISOMERASE-I INHIBITORS - TOPOTECAN AND IRENOTECAN

被引:242
作者
CREEMERS, GJ [1 ]
LUND, B [1 ]
VERWEIJ, J [1 ]
机构
[1] RIGSHOSP, DEPT ONCOL, DK-2100 COPENHAGEN, DENMARK
关键词
D O I
10.1016/0305-7372(94)90011-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:73 / 96
页数:24
相关论文
共 132 条
[1]   SELECTIVE INTERRUPTION OF HIGH MOLECULAR-WEIGHT RNA SYNTHESIS IN HELA-CELLS BY CAMPTOTHECIN [J].
ABELSON, HT ;
PENMAN, S .
NATURE-NEW BIOLOGY, 1972, 237 (74) :144-&
[2]  
ABIGERGES D, 1993, P AN M AM SOC CLIN, V12, P133
[3]   CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J].
ANDOH, T ;
ISHII, K ;
SUZUKI, Y ;
IKEGAMI, Y ;
KUSUNOKI, Y ;
TAKEMOTO, Y ;
OKADA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5565-5569
[4]  
ANZAI H, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P431
[5]   CAMPTOTHECIN, A SPECIFIC INHIBITOR OF TYPE-I DNA TOPOISOMERASE, INDUCES DNA BREAKAGE AT REPLICATION FORKS [J].
AVEMANN, K ;
KNIPPERS, R ;
KOLLER, T ;
SOGO, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) :3026-3034
[6]  
BEEK WT, 1991, CANCER BIOL, V2, P235
[7]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE NEW ANTITUMOR DRUG SK-AND-F 104864-A (NSC 609699) IN PLASMA [J].
BEIJNEN, JH ;
SMITH, BR ;
KEIJER, WJ ;
VANGIJN, R ;
HUININK, WWT ;
VLASVELD, LT ;
RODENHUIS, S ;
UNDERBERG, WJM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :789-794
[8]   SEQUENTIAL ADMINISTRATION OF CAMPTOTHECIN AND ETOPOSIDE CIRCUMVENTS THE ANTAGONISTIC CYTOTOXICITY OF SIMULTANEOUS DRUG ADMINISTRATION IN SLOWLY GROWING HUMAN COLON-CARCINOMA HT-29 CELLS [J].
BERTRAND, R ;
OCONNOR, PM ;
KERRIGAN, D ;
POMMIER, Y .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :743-748
[9]  
BISSERY M C, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P402
[10]  
BISSERY MC, 1992, 7TH P NCI EORTC S NE, P82